Synairgen (SNG)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

163.50p
   
  • Change Today:
    -1.90p
  • 52 Week High: 224.66
  • 52 Week Low: 77.00
  • Currency: UK Pounds
  • Shares Issued: 201.34m
  • Volume: 1,126,401
  • Market Cap: £329.19m
  • RiskGrade: 510

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth Not Available

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio Not Available
Price Book Ratio
48.2% below the market average48.2% below the market average48.2% below the market average48.2% below the market average48.2% below the market average
8.33% above the sector average8.33% above the sector average8.33% above the sector average8.33% above the sector average8.33% above the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
77.72% above the market average77.72% above the market average77.72% above the market average77.72% above the market average77.72% above the market average
67.74% above the sector average67.74% above the sector average67.74% above the sector average67.74% above the sector average67.74% above the sector average
Price Chg 3m
43.15% above the market average43.15% above the market average43.15% above the market average43.15% above the market average43.15% above the market average
29.03% above the sector average29.03% above the sector average29.03% above the sector average29.03% above the sector average29.03% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
49.65% above the market average49.65% above the market average49.65% above the market average49.65% above the market average49.65% above the market average
43.33% above the sector average43.33% above the sector average43.33% above the sector average43.33% above the sector average43.33% above the sector average
Momentum 20
70.12% above the market average70.12% above the market average70.12% above the market average70.12% above the market average70.12% above the market average
70.00% above the sector average70.00% above the sector average70.00% above the sector average70.00% above the sector average70.00% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin Not Available
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
78.54% below the market average78.54% below the market average78.54% below the market average78.54% below the market average78.54% below the market average
75% below the sector average75% below the sector average75% below the sector average75% below the sector average75% below the sector average
Forecast EPS
77.45% above the market average77.45% above the market average77.45% above the market average77.45% above the market average77.45% above the market average
37.50% above the sector average37.50% above the sector average37.50% above the sector average37.50% above the sector average37.50% above the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover Not Available
Operating Profit Loss
80.26% below the market average80.26% below the market average80.26% below the market average80.26% below the market average80.26% below the market average
76% below the sector average76% below the sector average76% below the sector average76% below the sector average76% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
38.57% above the market average38.57% above the market average38.57% above the market average38.57% above the market average38.57% above the market average
53.19% above the sector average53.19% above the sector average53.19% above the sector average53.19% above the sector average53.19% above the sector average
Cash
59.55% above the market average59.55% above the market average59.55% above the market average59.55% above the market average59.55% above the market average
68.00% above the sector average68.00% above the sector average68.00% above the sector average68.00% above the sector average68.00% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
33.81% above the market average33.81% above the market average33.81% above the market average33.81% above the market average33.81% above the market average
11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average
Buys 1y
73.33% below the market average73.33% below the market average73.33% below the market average73.33% below the market average73.33% below the market average
76.19% below the sector average76.19% below the sector average76.19% below the sector average76.19% below the sector average76.19% below the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
19.89% above the market average19.89% above the market average19.89% above the market average19.89% above the market average19.89% above the market average
58.62% above the sector average58.62% above the sector average58.62% above the sector average58.62% above the sector average58.62% above the sector average
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Synairgen Market Data

Currency UK Pounds
Share Price 163.50p
Change Today -1.90p
% Change -1.15 %
52 Week High 224.66
52 Week Low 77.00
Volume 1,126,401
Shares Issued 201.34m
Market Cap £329.19m
RiskGrade 510

Synairgen Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
48.13% above the market average48.13% above the market average48.13% above the market average48.13% above the market average48.13% above the market average
92.00% above the sector average92.00% above the sector average92.00% above the sector average92.00% above the sector average92.00% above the sector average
Price Trend
4.26% below the market average4.26% below the market average4.26% below the market average4.26% below the market average4.26% below the market average
16.13% above the sector average16.13% above the sector average16.13% above the sector average16.13% above the sector average16.13% above the sector average
Income
4.86% above the market average4.86% above the market average4.86% above the market average4.86% above the market average4.86% above the market average
63.64% above the sector average63.64% above the sector average63.64% above the sector average63.64% above the sector average63.64% above the sector average
Growth Not Available

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Synairgen Dividends

No dividends found

Trades for 21-Sep-2021

Time Volume / Share Price
16:35 8,082 @ 163.50p
16:29 14 @ 161.50p
16:29 27 @ 161.50p
16:29 11 @ 161.50p
16:29 531 @ 161.60p

Synairgen Key Personnel

CEO Richard J Marsden
Finance Director John C Ward

Top of Page